128 related articles for article (PubMed ID: 27188412)
1. Primary central nervous system posttransplant lymphoproliferative disease: An uncommon diagnostic dilemma.
Degen D; Kanellis J; Hughes P; Barit D; Ierino F
Nephrology (Carlton); 2016 Jun; 21(6):528. PubMed ID: 27188412
[No Abstract] [Full Text] [Related]
2. [Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir].
Hansen PB; Al-Farra G
Ugeskr Laeger; 2010 Oct; 172(42):2907-8. PubMed ID: 21040668
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient.
Khalil M; Enzinger C; Wallner-Blazek M; Scarpatetti M; Barth A; Horn S; Reiter G
J Neurovirol; 2008 Nov; 14(6):574-8. PubMed ID: 18991070
[TBL] [Abstract][Full Text] [Related]
4. Monomorphic Epstein-Barr virus (EBV)-associated large B-cell posttransplant lymphoproliferative disorder presenting as a tongue ulcer in a pancreatic transplant patient.
Bruce AJ; Subtil A; Rogers RS; Castro LA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):e24-8. PubMed ID: 16997090
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemia after simultaneous pancreas-kidney transplant: fact or factitious?
Donegan D; Hickey DP; Smith D
Pancreas; 2012 Aug; 41(6):974-6. PubMed ID: 22781913
[No Abstract] [Full Text] [Related]
6. A long-term prevention of diabetic nephropathy in a patient with type 1 diabetes after simultaneous pancreas and kidney transplantation.
Nyumura I; Honda K; Babazono T; Taneda S; Horita S; Teraoka S; Yamaguchi Y; Iwamoto Y; Oda H
Clin Transplant; 2009 Aug; 23 Suppl 20():54-7. PubMed ID: 19594598
[TBL] [Abstract][Full Text] [Related]
7. Ocular involvement by epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: a new disease entity in the world health organization classification.
Tsuji H; Tamura M; Yokoyama M; Takeuchi K; Mimura T
Arch Ophthalmol; 2010 Feb; 128(2):258-9. PubMed ID: 20142557
[No Abstract] [Full Text] [Related]
8. Treatment of Primary Central Nervous System Posttransplant Lymphoproliferative Disorder in an Adult Kidney Transplant Recipient: A Case Report.
Abbassi M; Riley R; Malkin M; Tang Y; Rajendran B; Yazbeck V
Exp Clin Transplant; 2019 Feb; 17(1):111-114. PubMed ID: 28447926
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders.
Boratyńska M; Smolska D
Transpl Int; 2008 Jun; 21(6):605-8. PubMed ID: 18282244
[No Abstract] [Full Text] [Related]
10. Specific humoral rejection of a pancreas allograft in a recipient of pancreas after kidney transplantation.
Carbajal R; Karam G; Renaudin K; Maillet F; Cesbron A; Rostaing L; Cantarovich D; Soulillou JP; Blancho G
Nephrol Dial Transplant; 2007 Mar; 22(3):942-4. PubMed ID: 17210592
[No Abstract] [Full Text] [Related]
11. Central nervous system vasculitis: all that glitters is not gold.
Haroon M; Molloy E; Farrell M; Alraqi S
J Rheumatol; 2012 Mar; 39(3):662-3. PubMed ID: 22383360
[No Abstract] [Full Text] [Related]
12. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM
Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113
[TBL] [Abstract][Full Text] [Related]
13. Leukocytoclastic vasculitis as early manifestation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Zoroquiain P; González S; Molgó M; Rodríguez A; Valbuena JR
Am J Dermatopathol; 2012 May; 34(3):330-4. PubMed ID: 22197862
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant lymphoproliferative disorder presenting as multiple myeloma.
Ninan MJ; Datta YH
Am J Hematol; 2010 Aug; 85(8):635-7. PubMed ID: 20578201
[No Abstract] [Full Text] [Related]
15. Best option for transplant candidates with type 1 diabetes and a live kidney donor: a bird in the hand is worth two in the bush.
Reese PP; Israni AK
Clin J Am Soc Nephrol; 2009 Apr; 4(4):700-2. PubMed ID: 19339429
[No Abstract] [Full Text] [Related]
16. Outcome of combined kidney/pancreas transplantation in recipients with coronary artery disease.
Kim SI; Elkhammas EA; Henry ML; Davies EA; Bumgadner GL; Ferguson RM
Transplant Proc; 1995 Dec; 27(6):3071. PubMed ID: 8539847
[No Abstract] [Full Text] [Related]
17. Delayed kidney allograft function after simultaneous pancreas-kidney transplantation.
Rangel EB; Melaragno CS; Gonzalez AM; Linhares MM; de Sá JR; Salzedas A; Medina-Pestana JO
Transplant Proc; 2010 Nov; 42(9):3655-9. PubMed ID: 21094834
[TBL] [Abstract][Full Text] [Related]
18. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant lymphoproliferative disorder after kidney transplantation: time to adopt monitoring of Epstein-Barr virus?
Biller P; Michaux L; Pauw LD; Camboni A; Mourad M; Kanaan N
Acta Clin Belg; 2015 Jun; 70(3):218-22. PubMed ID: 25541210
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.
van de Glind G; de Graaf S; Klein C; Cornelissen M; Maecker B; Loeffen J
Pediatr Blood Cancer; 2008 Apr; 50(4):886-8. PubMed ID: 17668865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
